Τόμος 10 (1996) – Τεύχος 3 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 10 (1996) – Issue 2 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

School of Health Sciences, Department of Pharmacy, Laboratory of Pharmaceutical Chemistry, University of Patras, Patras, Greece

Accepted for publication: 1 October 1996

pharmakonpress[at]pharmakonpress[.]gr

2.    Bardos T.J., Chmielewicz Z.F., Hebborn P.: Structure-activity relationships of alkylating agents in cancer chemotherapy. Ann. N. Y. Acad. Sci. 163: 1006-1025 (1962)

3.    Hebborn P., Simpson C.L., Mihich E.: Antitumor and toxicologic effects of p-carboxycarbanilic acid N-p-bis(2-chlo- roethyl)aminophenyl ester. Cancer Chem. Rep. 54: 23-30 (1970)

4.    Wall M.E., Abernethy G., Carroll Jr F.I., Taylor D.J.: The effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems. J. Med. Chem. 12: 810-818 (1969)

5.    Carroll F.I., Philip A., Blakwell J.T., Taylor J., Wall M.E.: Antitumor and antileukemic effects of some steroids and other biologic interesting compounds containing an alkylating agent. J. Med. Chem. 15: 1158-1161 (1972)

6.    Jonson G., Hogberg B.t Nilson T.: Treatment of advanced prostatic carcinoma with estramustine phosphate. Scand. J. Urol. Nephrol. 11: 231-238 (1977)

7.    Brandt I., Konyves I.: Therapeutic effect of Prednimustine (Leo 1031) in various types of leukemia. Eur. J. Cancer 13: 393-398 (1977)

8.    Kaufman J.N., Hanjura G.L., Mittelman A., Aungst C.W., Murphy G.P.: Study of Leo 1031 (NSC 134087) in lymphocytic lymphoma and chronie lymphatic leukemia. Cancer Treat. Rep. 60: 277-279 (1976)

9.    Konyves I., Nordonskjold B., Plym Forshell G., de Schryver A., Westerberg-Larsson N.: Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinoma. Eur. J. Cancer 11: 841-844 (1975)

10.  Lole S.B., Piver M.S., Barlow J., Murphy G.P.: Leo 1031 (NSC 134087) in gynecological malignancies. Oncology 35: 101-102 (1978)

11.  Wampler G.L., Catsoulacos P.: Antileukemic effect of homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenylacetic acid. Cancer Treat. Rep. 61: 37-41 (1977)

12.  Catsoulacos P.: Further studies of the antineoplastic activity of 3β-hydroxy-13α-amino-13,17-seco-5α-androstan-17-oic-13,17-lactam-p-N,N-bis(2-chloroethyl)aminophenyfacetate. Cancer Lei 22: 199-209 (1984)

13.  Catsoulacos P., Politis D., Wampler G.L.: A new steroidal alkylating agent with activity in advanced murine leukemias. Cancer Chemother. Pharmacol. 3: 67-70 (1979)

14.  Dalmases P., Gomez-Belinchon J.I., Bonet J.-J., Giner-Sorolla A., Schmid F.A>: Antineoplastic agents. A nitrogen mustard derivative of a N-methylated steroidal lactam. Eur. J. Med. Chem. 6: 541-543 (1983)

15.  Dalmases P., Cervantes G., Quintana J., Bonet J.-J., Giner-Sorolla A., Schmid F.A.: Antineoplastic agents. Nitrogen mustards of systematically modified steroidal ring A lactams. Eur. J. Med. Chem. 19: 465-467 (1984)

16.  Dalmases P., Caselles M.C., Serra J., Quintana J., Bonet J.-J., Giner-Sorolla A., Schmid F.A.: Nitrogen mustards of systematically modified steroidal ring A-homo-lac- tams. Eur. J. Med. Chem. 20: 471-474 (1985)

17.  Catsoulacos P., Pairas G.: Activity of 17P-hydroxy-3-aza- A-homo-4α-androsten-4-one-p-N,N-bis(2-chlo- roethyl)aminophenoxyacetate (NSC 620480) in P388 leukemia. Activity of steroidal lactams in Ehrlich tumor. Meth. Find. Exp. din. Pharmacol. 12: 501-505 (1990)

18.  Tselepi M.R., Demopoulos N.A., Catsoulacos P.: Induction of sister chromatid exchanged and cell division delays in human lymphocytes by the antitumor agent homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenoxyacetic acid. Mutagenesis 4: 361-364 (1989)

19.  Stephanou G., Demopoulos N.A., Catsoulacos P.: Genotoxic effect of the antitumor agent homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenoxyacetic acid (NSC 294859) tested in the Drosophila wing somatic mutation and recombination test. Mutagenesis 6: 325-328 (1991)

20.  Catsoulacos P., Camoutsis Ch., Papageorgiou A., Margariti E.: Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-activity relationships. Anticancer Res. 12: 1617-1620 (1992)

21.  Athanasiou A., Catsoulacos P., Papageorgiou A., Athanasiou K.: Response of transplantable tumors in mice of macromolecular synthesis to l7p-acetamido-3-aza-A-homo-4α-androsten-4-one. Cancer invest. 5: 301-307 (1987)

22.  Politis G., Catsoulacos P.: Effects of homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenylacetic acid on lymphocytes stimulated with PNA in vitro. J. Steroid. Biochem. 9: 599-602 (1978)

23.  Politis G., Camoutsis Ch., Catsoulacos P.: Proliferation of human acute leukemia cells in cultures on treatment with an homo-aza-steroid. Meth. Find. Exptl. Clin. Pharmacol. 4: 406 (1982)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr